Post by
modulex on Feb 15, 2016 7:59am
SHAREHOLDERS WHO VOTES (YES) MUST NOT COMPLAIN
Diagnocure's shareholders who endorsed the PCA3 asset sale are first lousy to have done so and secondly they should not complain if things do not end up positively for the remaining possible asset sales of GCC and PRP. It was clearly states in the Circular Notice that the shares would become unable to meet the listing requirements, therefore likely delisted after the transaction. That fact alone was warranted for rejecting the asset sale. What's the use to be a shareholder if you can't trade your shares. It is illogic. The whole problem is that Diagnocure management surrendered, so to speak, to Hologic's scheme. Hologic will now, being in total control of PCA3, market this test and reap up million of dollars in the coming years. When CUR shares become delisted, you have to watch afterwards if Board members starts to resign. If so, Diagnocure may just become a dormant company. If its remaining assets can't be sold, it should be watched if any insider does not take these assets and create a new company. Shareholders can be left in the dark and ultimately not hear back of what's happening. And bang, one day, Diagnocure is gone with the wind.
Comment by
oceanblvd on Feb 24, 2016 10:04am
what does that mean ? PCA3 was a gold mine we just had incompetant miners .